{"nctId":"NCT01423617","briefTitle":"Efficacy and Safety of Zenoctil in Reducing Body Weight","startDateStruct":{"date":"2011-07"},"conditions":["Overweight"],"count":92,"armGroups":[{"label":"Zenoctil","type":"ACTIVE_COMPARATOR","interventionNames":["Dietary Supplement: Zenoctil"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Other: Placebo"]}],"interventions":[{"name":"Zenoctil","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Caucasian males and females, age 18 to 60 years\n* 25 kg/m2 ≤ BMI ≤32 kg/m2\n* Expressed desire for weight loss\n* Accustomed to 3 main meals a day\n* Consistent and stable body weight 3 months prior to study enrollment\n* Commitment to avoid the use of other weight loss products/programs during the study\n* Commitment to adhere to diet recommendation\n* Females' agreement to use appropriate birth control methods during the active study period\n* Subject declares in writing his/her consent to participate, understands requirements of the study and is willing to comply\n\nExclusion Criteria:\n\n* Known sensitivity to Garcinia cambogia, Lagerstroemia speciosa (other members of Lythraceae family), caffeine, tannins\n* History of diabetes mellitus or other endocrine disorders\n* Fasting blood glucose \\>7 mmol/L\n* Treatment with systemic corticosteroids within the last 12 months\n* Current use of antidepressants\n* Uncontrolled hypertension (\\>160/110) or other uncontrolled cardiac, pulmonary, renal, or liver disease, determined to be clinically significant by the investigator\n* Presence of acute or history of chronic gastrointestinal disease\n* Schizophrenia or other diagnosed psychiatric disorders\n* Any other acute or chronic disease or any other medical condition which, in the investigator's view, may preclude subject's inclusion (e.g., cancer, HIV)\n* Bariatric surgery\n* Abdominal surgery within the last 6 months\n* History of eating disorders like bulimia, anorexia nervosa\n* Changes in the dose of estrogen, contraceptives or thyroid hormone within the last 3 months\n* Pregnancy or nursing\n* Any medication or use of products for the treatment of obesity (e.g., fat binder, carbohydrate blocker/starch blocker, fat burner, satiety products etc.) within the last 6 weeks\n* More than 3 hours strenuous sport activity per week\n* History of abuse of drugs, alcohol or medication\n* Smoking cessation within the 6 months prior to this study\n* Incompliance due to language difficulties\n* Participation in another study during the last 4 weeks\n* Clinically relevant excursions of safety parameters","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"60 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Mean Body Weight (kg)","description":"Change in mean body weight at week 12 compared to baseline.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.26","spread":"2.37"},{"groupId":"OG001","value":"-0.56","spread":"2.45"}]}]}]},{"type":"PRIMARY","title":"Change in Mean Body Fat (kg)","description":"Change in mean body fat at week 12 compared to baseline","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.12","spread":"1.84"},{"groupId":"OG001","value":"0.37","spread":"2.14"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Who Lost at Least 3% of Baseline Body Weight","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Changes in Waist Circumference (cm)","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.00","spread":"2.44"},{"groupId":"OG001","value":"-0.69","spread":"2.24"}]}]}]},{"type":"SECONDARY","title":"Changes in Hip Circumference","description":null,"paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.54","spread":"1.76"},{"groupId":"OG001","value":"0.64","spread":"1.91"}]}]}]},{"type":"SECONDARY","title":"Changes in Waist-hip-ratio","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Changes in Body Fat Content (%)","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Changes in Hunger, Eating, and Food-craving Related Items From the Control of Eating Questionnaire (COEQ)","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Subjects' Global Feeling of Satiety","description":"Subject's feeling of satiety (subsequent to the three main meals) is judged globally by the subjects on the basis of a 4 point rating scale: 0 = \"no\"; 1 = \"slightly\", 2 = \"moderate\" and 3 = \"strong\".","paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Changes in Body Fat Free Mass (kg)","description":null,"paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Global Evaluation of Safety by Investigators","description":"The investigators evaluate independently the safety of the investigational product, using a scale with scores of \"very good\", \"good\", \"moderate\" and \"poor\".","paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Global Evaluation of Safety by Subjects","description":"The subjects evaluate independently the safety of the investigational product, using a scale with scores of \"very good\", \"good\", \"moderate\" and \"poor\".","paramType":null,"dispersionType":null,"classes":[]},{"type":"SECONDARY","title":"Global Evaluation of Efficacy by Subjects","description":"The subjects evaluate independently the efficacy of the investigational product, using a scale with scores of \"very good\", \"good\", \"moderate\" and \"poor\".","paramType":null,"dispersionType":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":46},"commonTop":[]}}}